Tuhura Biosciences Inc (HURA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 06-2024 | 12-2023 | 06-2023 | 06-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 12,657 | N/A | 3,665 | 1,535 | 11,780 |
| Other current assets | 6,953 | 0 | 494 | 1,075 | 0 |
| TOTAL | $19,610 | $N/A | $4,159 | $3,270 | $13,258 |
| Non-Current Assets | |||||
| PPE Net | 123 | N/A | 182 | 709 | 90 |
| Other Non-Current Assets | 233 | 0 | 21 | 0 | 2,600 |
| TOTAL | $356 | $N/A | $203 | $709 | $2,690 |
| Total Assets | $19,967 | $N/A | $4,362 | $3,979 | $15,948 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 5,170 | 0 | 3,439 | 3,082 | 3,990 |
| Other current liabilities | N/A | N/A | 137 | N/A | N/A |
| TOTAL | $5,330 | $N/A | $3,596 | $3,082 | $3,990 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 43 | 0 | 2,324 | 166 | 163 |
| TOTAL | $43 | $N/A | $2,324 | $166 | $163 |
| Total Liabilities | $5,373 | $N/A | $5,921 | $3,248 | $4,153 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 43,680 | N/A | 1,116 | N/A | N/A |
| Common Shares | 42 | N/A | 12 | 2 | 1 |
| Retained earnings | -111,125 | N/A | -88,475 | -151,375 | -136,356 |
| Other shareholders' equity | 0 | 0 | 0 | 21 | 21 |
| TOTAL | $14,594 | $N/A | $-1,559 | $731 | $11,795 |
| Total Liabilities And Equity | $19,967 | $0 | $4,362 | $3,979 | $15,948 |